compound 6b [PMID: 24999562] [2332]
compound 6b [PMID: 24999562]
| SMILES |
CC(C)CC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CCC1CCCCC1)C(=O)N[C@@H](CN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(N)=O |
| InChIKey |
KAFZOLYKKCWUBI-HPMAGDRPSA-N |
| Sequence |
None |
| HELM |
PEPTIDE1{[*C(=O)CCC1CCCCC1 |$_R2;;;;;;;;;;$|].L.[*C(=O)[C@H](CCC(C)C)N* |$_R2;;;;;;;;;;_R1$|].[Dpr].P.R.N.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
10 |
| Hydrogen bond donors |
11 |
| Rotatable bonds |
26 |
| Log P |
-1.173 |
| Molecular weight (Da) |
848.6 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
compound 6b [PMID: 24999562]
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.